TOBI, Lösung zur Inhalation mit einem Vernebler

7680556990029 CH-55699 Lösung zur Inhalation mit einem Vernebler
TOBI, Lösung zur Inhalation mit einem Vernebler
TOBI, Lösung zur Inhalation mit einem Vernebler
TOBI, Lösung zur Inhalation mit einem Vernebler
1 / 3
google

Article details

Package size
56
Selling units
56
Measure
Ampulle(n)
Galenic form
Lösung zur Inhalation mit einem Vernebler
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/06/2025
Patient information leaflet
Français
27/06/2025
Patient information leaflet
Italien
27/06/2025
Summary of Product Characteristics
Allemand
27/06/2025
Summary of Product Characteristics
Français
27/06/2025
Summary of Product Characteristics
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
300.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2546.65
Specialties list
Yes
Generic
No
SL addition date: 01/01/2002

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
55699
Drug name
TOBI, Lösung zur Inhalation mit einem Vernebler
Galenic form
LSVE
ATC Code
J01GB01
Authorization status
Z
Dispensing category
A
First authorization
21/12/2001
Authorization expiration date
31/12/9999
IT Number
08.01.7.
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
TOBI sol inhal 300 mg/5ml 56 amp 5 ml
Description (DE)
TOBI Inhal Lös 300 mg/5ml 56 Amp 5 ml
Market launch
21/12/2001
Narcotic (BTM)
No